Page last updated: 2024-10-26

diphenyleneiodonium and Hepatoblastoma

diphenyleneiodonium has been researched along with Hepatoblastoma in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Schulz, C1
Jung, F1
Küpper, JH1

Other Studies

1 other study available for diphenyleneiodonium and Hepatoblastoma

ArticleYear
Inhibition of phase-1 biotransformation and cytostatic effects of diphenyleneiodonium on hepatoblastoma cell line HepG2 and a CYP3A4-overexpressing HepG2 cell clone.
    Clinical hemorheology and microcirculation, 2021, Volume: 79, Issue:1

    Topics: Biotransformation; Cell Line; Clone Cells; Cytochrome P-450 CYP3A; Cytostatic Agents; Hep G2 Cells;

2021